Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07227493 · ClinicalTrials.gov registry record
Open Pilon With FIBERGRAFT AERIDYAN Matrix Bioactive Glass
A clinical trial of Open Pilon Fractures, sponsored by University of Missouri-Columbia.
- Recruiting
- Registry status
- 45
- Enrollment target
- 1
- Study location
NCT07227493 is a study of Open Pilon Fractures that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07227493, a study of Open Pilon Fractures, is actively recruiting participants, sponsored by University of Missouri-Columbia.
- RECRUITING
- Registry status
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
Open pilon fractures are challenging problems to manage. Infection rates vary from 6-30% and metaphyseal nonunion varies from 7-20%. The current recommendation for the management of open pilon fractures with bone loss is a staged approach, with internal fixation around an antibiotic spacer. Fibergraft Aeridyan Bone Graft Matrix is currently used along with other forms of allograft at our institution for filling bone voids in open pilon fractures. This is a prospective, observational study looking at the use of Fibergraft Aeridyan bone graft matrix and its efficacy in open pilon fractures. Everything in this study will be according to the standard of care at our institution other than two research only CT scans. One will be performed at the patient's 6-month visit and the other will be performed at the patient's 12-month visit. The investigators hypothesize that Fibergraft Aeridyan Bone Graft Matrix will lead to improved outcomes when compared to standard bone graft for patients by decreasing infection and nonunion rates.
Conditions Studied
Interventions
- DEVICE Fibergraft Aeridyan Matrix
Study Locations (1)
Missouri
- University of Missouri - Columbia - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2025-10-24 |
| Est. Completion | 2027-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07227493
The ClinicalTrials.gov registry entry for NCT07227493 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Open Pilon Fractures appearing as the primary indexed condition, and to 1 intervention - of which Fibergraft Aeridyan Matrix is the first listed.
NCT07227493 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT07227493 about?
NCT07227493 is a clinical study titled "Open Pilon With FIBERGRAFT AERIDYAN Matrix Bioactive Glass". Open pilon fractures are challenging problems to manage. Infection rates vary from 6-30% and metaphyseal nonunion varies from 7-20%. The current recommendation for the management of open pilon fractures with bone loss is a staged approach, with internal fixation around an antibiotic spacer. Fibergra...
What is the current status of trial NCT07227493?
This trial is currently recruiting. The enrollment target is 45 participants. The study started on 2025-10-24. Estimated completion is 2027-01.
What conditions does trial NCT07227493 study?
This clinical trial studies the following conditions: Open Pilon Fractures.
What interventions are being tested in trial NCT07227493?
The interventions under investigation include: Fibergraft Aeridyan Matrix (DEVICE).
Who is sponsoring clinical trial NCT07227493?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07227493 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.